2h3v: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 2h3v |SIZE=350|CAPTION= <scene name='initialview01'>2h3v</scene> | |PDB= 2h3v |SIZE=350|CAPTION= <scene name='initialview01'>2h3v</scene> | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand=PIO:L-ALPHA-D-MYOPHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE, D(+)SN1,2DI-O-OCTANOYLGLYCERYL'>PIO</scene> | |LIGAND= <scene name='pdbligand=PIO:L-ALPHA-D-MYOPHOSPHATIDYLINOSITOL+4,5-BISPHOSPHATE,+D(+)SN1,2DI-O-OCTANOYLGLYCERYL'>PIO</scene> | ||
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
|DOMAIN= | |||
|RELATEDENTRY=[[2h3f|2H3F]], [[2h3i|2H3I]], [[2h3q|2H3Q]], [[2h3z|2H3Z]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2h3v FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2h3v OCA], [http://www.ebi.ac.uk/pdbsum/2h3v PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2h3v RCSB]</span> | |||
}} | }} | ||
| Line 28: | Line 31: | ||
[[Category: Summers, M F.]] | [[Category: Summers, M F.]] | ||
[[Category: Tai, J.]] | [[Category: Tai, J.]] | ||
[[Category: hiv-1 unmyristoylated ma protein]] | [[Category: hiv-1 unmyristoylated ma protein]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 03:25:09 2008'' | ||
Revision as of 03:25, 31 March 2008
| |||||||
| Ligands: | |||||||
| Related: | 2H3F, 2H3I, 2H3Q, 2H3Z
| ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
Structure of the HIV-1 Matrix protein bound to di-C8-phosphatidylinositol-(4,5)-bisphosphate
OverviewOverview
During the late phase of HIV type 1 (HIV-1) replication, newly synthesized retroviral Gag proteins are targeted to the plasma membrane of most hematopoietic cell types, where they colocalize at lipid rafts and assemble into immature virions. Membrane binding is mediated by the matrix (MA) domain of Gag, a 132-residue polypeptide containing an N-terminal myristyl group that can adopt sequestered and exposed conformations. Although exposure is known to promote membrane binding, the mechanism by which Gag is targeted to specific membranes has yet to be established. Recent studies have shown that phosphatidylinositol (PI) 4,5-bisphosphate [PI(4,5)P(2)], a factor that regulates localization of cellular proteins to the plasma membrane, also regulates Gag localization and assembly. Here we show that PI(4,5)P(2) binds directly to HIV-1 MA, inducing a conformational change that triggers myristate exposure. Related phosphatidylinositides PI, PI(3)P, PI(4)P, PI(5)P, and PI(3,5)P(2) do not bind MA with significant affinity or trigger myristate exposure. Structural studies reveal that PI(4,5)P(2) adopts an "extended lipid" conformation, in which the inositol head group and 2'-fatty acid chain bind to a hydrophobic cleft, and the 1'-fatty acid and exposed myristyl group bracket a conserved basic surface patch previously implicated in membrane binding. Our findings indicate that PI(4,5)P(2) acts as both a trigger of the myristyl switch and a membrane anchor and suggest a potential mechanism for targeting Gag to membrane rafts.
About this StructureAbout this Structure
2H3V is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
ReferenceReference
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly., Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF, Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11364-9. Epub 2006 Jul 13. PMID:16840558
Page seeded by OCA on Mon Mar 31 03:25:09 2008